lifestyle questionnaire. The cohort was followed until 1999 (NIPPON DATA80). [13] [14] [15] [16] The overall population aged 30 years in the 300 participating health districts was 13,771. Therefore, the participation rate of the survey was 76.6% before exclusion for the following reasons: missing information on the baseline survey (n=76); lost to follow up (n= 989); age ≥70 years (n=950); any individual with a history of myocardial infarction, stroke or angina pectoris (n=192). We analyzed data from the remaining 8,339 individuals (3,658 men and 4,681 women).
Endpoint Determination
National Vital Statistics was used to clarify the cause of death. In accordance with Japan's Family Registration Law, all death certificates issued by physicians are forwarded to the Ministry of Health and Welfare via public health centers in the district of residence. The underlying causes of death were coded according to the 9 th and 10 th revisions of the International Classification of Diseases for the National Vital Statistics. We confirmed death in each health district by computer matching data from the National Vital Statistics with district, gender, and dates of birth and death as key codes. Permission to use the National Vital Statistics was obtained from the Management and Coordination Agency, Government of Japan. Ethical approval for this study was obtained from the Institutional Review Board of Shiga University of Medical Science (No. [12] [13] [14] [15] [16] [17] [18] 2000) .
Baseline and Biochemical Examinations
The baseline surveys were conducted by public health centers. Baseline BP was measured by trained observers using a standard mercury sphygmomanometer affixed to the right arm of seated participants who had rested for 5 min. Height in stockinged feet and weight in light clothing were measured. Body mass index (BMI) was calculated as weight (kg) divided by the square of the height (m). Results of a self-administered questionnaire that included questions about participants' smoking habits, alcohol consumption, current health status and medical history were obtained. Non-fasting or fasting (at least 5 h after the last meal) blood samples were centrifuged at room temperature for 15 min at 1,500 g and within 60 min of collection, and then stored at -70°C. Serum TC concentration was analyzed at a single laboratory (Osaka Medical Center for Health Science and Promotion, Osaka, Japan), using a sequential auto analyzer (SMA12; Technicon, Tarrytown, NY, USA) and the Lieberman -Burchard direct method. This laboratory is a member of the Cholesterol Reference Method Laboratory Network, and the precision and accuracy of serum cholesterol measurements have been certified in the Lipid Standardization Program, administered by the Centers for Disease Control and Prevention, Atlanta. 17 Serum glucose concentrations measured by the cupric neocuproline method were converted into the values used in the hexokinase method. 18 The cohort was divided into the categories 'low risk' and 'other'. Low risk was defined as having the following characteristics at the time of the baseline survey: BP <120/80 mmHg, a level categorized as normal by the JNC 7; 19 no antihypertension medication; TC 160-240 mg/dl (4.14-6.22 mmol/L); non-fasting serum glucose <200 mg/dl (11.1 mmol/L) or fasting serum glucose <126 mg/dl (7.0 mmol/L); no history of diabetes; and not currently smoking. Although other papers define TC <200 mg/dl (5.18 mmol/L) as low risk for CVD, 1,2,5-7 we defined TC as low risk because low TC (ie, <160 mg/dl (4.14 mmol/L)) is associated with increased risk of cerebral hemorrhage, 13, 20, 21 and risk for CVD is not increased significantly at TC levels between 200 and 240 mg/dl (5.18-6.22 mmol/L) in Japan. 13 
Statistical Analysis
All statistical analyses were performed using SAS version 8.02 for WINDOWS (SAS Institute Inc, Cary, NC, USA). Men and women were first analyzed separately and then together. We used the chi-squared and t-test to compare dichotomous and continuous variables, respectively. The age-adjusted and multivariate-adjusted hazard ratios (HR) for all-cause and cause-specific mortality were calculated using a Cox proportional hazard model. For multivariate analyses, age, gender, BMI and frequency of alcohol consumption (ie, occasional, daily or none) were entered as covariates. The significance of an interaction between gender and low-risk status for all-cause and cause-specific mortality was tested using an interaction term for the continuous and categorical variables in a multivariate-adjusted model. All p-values were 2-tailed and p<0.05 was considered significant. Data are presented as the means ± SD unless otherwise stated. We also calculated the population-attributable fraction for all-cause death among the risk factors by the formula 22 :
[Proportion of cases exposed to risk factor × (Adjusted HR -1)/Adjusted HR]. Table 1 shows the baseline characteristics of the 2 categories of participants. Those with a low risk accounted for 9.4% of the total and contained a higher proportion of women. The mean values for age, BMI, systolic BP (SBP), diastolic BP (DBP) and glucose concentrations differed significantly between the 2 groups.
Results

Baseline Characteristics
Mortality by Cause, Low Risk vs Other
Among 109 low-risk men and 675 low-risk women, 9 (all-cause mortality rate, 4.6/1,000 person-years) and 30 (all-cause mortality rate, 2.4/1,000 person-years) died, respectively. These all-cause mortality rates in low-risk participants were lower than those in others (10.4/1,000 person-years in others men and 6.1/1,000 person-years in others women). For both men and women, the multivariateadjusted HRs (95% confidence intervals (CI)) for all-cause death in low-risk individuals were significantly lower than those in the other group; HR =0.47 (0.24-0.90) in men and HR =0.73 (0.50-1.06) in women. As we did not find any significant relationship between gender and low-risk profile for mortalities (p=0.17 for all-cause and p=0.58 for CVD death), we combined the data from men and women in the analyses that followed. Table 2 shows the number of deaths, age-adjusted rates per 1,000 person-years and the HR of low-risk individuals for all-cause and cause-specific mortality. Crude mortality rates per 1,000 person-years for CVD were 0.4 and 2.5 among the low risk and the other group, respectively. Similarly, all-cause mortality per 1,000 person-years was 2.6 for low risk and 8.0 for the other group. The multivariate-adjusted HRs for CVD death and all-cause death in low-risk individuals were significantly lower than for those in the other group; HR =0.33 (95% CI, 0.15-0.74) for CVD mortality and 0.63 (0.46-0.88) for all-cause mortality. The frequency of deaths due to stroke was only 1 in 784 low-risk individuals (0.1 per 1,000 person-years), but was 154 in 7,555 of the other group (1.1 per 1,000 person-years). Although the risk of cancer mortality was also slightly lower in low-risk individuals (HR =0.90; 0.57-1.40), the difference was not statistically significant. Table 3 shows multivariate-adjusted HRs for all-cause death according to major CVD risk factors and their population-attributable risk fractions (%). The proportion of cases exposed to non-normal BP, currently smoking were 91.8%, 46.6%, 30.1% and 9.4% of all deaths, respectively. The HRs for high BP, smoking, diabetes, serum cholesterol and all-cause mortality were 1.40 (1.13-1.74), 1.51 (95% CI, 1.31-1.74), 1.20 (1.06-1.37) and 1.81 (1.48-2.22), respectively. Accordingly, the population-attributable risk ratios for all-cause mortality were 26.2%, 15.7%, 5.1% and 4.2% for high BP, smoking, non-optimal serum cholesterol and diabetes, respectively. When we calculated the populationattributable risk fraction for each gender, the populationattributable risk ratios for all-cause death in men were 20.8%, 20.5%, 5.0% and 4.5% for high BP, smoking, nonoptimal serum cholesterol and diabetes, respectively, and were 31.8%, 6.0%, 5.6% and 3.2% in women, respectively.
Population-Attributable Risk of CVD Risk Factors for All-Cause Mortality
Discussion
We found that only a few middle-aged adults had a lowrisk profile for CVD. We also found that participants with a low-risk profile had a lower risk not only for CVD mortality but also for all-cause mortality. Moreover, among the major CVD risk factors, we discovered that the populationattributable risk for all-cause death was highest for high BP, followed by smoking.
One of the previous studies based on 5 large cohorts studies, involving a 16-year follow-up study of Multiple Risk Factor Intervention Trial (MRFIT) and a 22-year follow-up study of Chicago Heart Association Detection Project in Industry, 5 showed that long-term mortality rates for individuals with favorable CVD risk factor profiles in youth and middle age were much lower than those of individuals having at least one of the risk factors. They defined low risk as serum cholesterol level <200 mg/dl (<5.17 mmol/L), BP ≤120/80 mmHg and currently non-smoking. In that study, low-risk individuals comprised only 4.8-9.9% and the age- adjusted relative risks ranged from 0.42 to 0.60 for allcause mortality and from 0.15 to 0.28 for CVD mortality, respectively. 1 Another previous study that also investigated low-risk profiles is that by Daviglus and colleagues, who studied 7,302 women (aged 18-39 years) without prior CHD or major electrocardiographic abnormalities, screened between 1967 and 1973, for the Chicago Heart Association Detection Project in Industry. 5 They found that only 20% met all the criteria for low-risk profile, which they defined as: TC <200 mg/dl; BP ≤120/80 mmHg; BMI <25 kg/m 2 ; no anti-hypertensive or cholesterol-lowering medication; no diabetes; and no smoking. They also showed the multivariate-adjusted all-cause relative risk for low-risk women was 0.19 compared with women with 2 or more high-risk factors. 5 Giampaoli and colleagues' conducted a 10-year follow-up study of Italian participants aged 35-69 years from 12 population samples. 6 They defined low risk as having all of the following applied at baseline: SBP <120 mmHg; DBP <80 mmHg; receiving no hypertensive drug treatment; serum TC <5.17 mmol/L (<200 mg/dl); BMI, <25.0 kg/m 2 ;
non-smoker; and no diabetes. They found that all the factors could be applied to only 3.5% of women and 1.6% of men. 6 Lloyd-Jones et al studied all Framingham Heart Study participants who were free of CVD at 50 years of age. 7 They found that only 3.2% of men and 4.5% of women had all the optimal factors; that is, TC <4.65 mmol/L (<180 mg/dl), BP <120/<80 mmHg, non-smoker and non-diabetic. 7 When our results for relative risk of low-risk profile for all-cause mortality are compared with those of Stamler et al, 1 whose study used similar criteria and compared the risk of low-risk profile with all others as we did, our results are somewhat modest. Various reasons could explain these discrepancies, which will now be considered. Since we used the low-risk profile for CVD mortality in these studies, the proportion of CVD deaths in all deaths can explain the discrepancy. The World Health Organization's Health Statistics and Health Information Systems 9 displays a table regarding numbers and rates of registered deaths. In 2000 in Japan, death due to diseases of the circulatory system (ICD10: I00-I99) accounted for 27.5% of all deaths in men and 35.3% of all deaths in women. 9 Corresponding values for the same year in the USA was 37.2% for all-cause mortality in men and 41.1% in women. 9 Moreover, mortality rates in Japan due to stroke, which occurs in relatively older individuals, are still higher than those due to CHD, which results in death among younger individuals. 8 Another reason could be that most Japanese men are likely to have been smokers in the past, 8 whereas men who have never smoked might have had a health condition in their youth, such as tuberculosis or asthma. Thus, relatively weaker men might be included in the 'low risk' group. However, as we did not obtain information about participants' histories of nonCVDs, we can't confirm this speculation.
Although the definition we used was different, the proportion of individuals with a low-risk profile in the present study was mostly similar to that of other studies (3-10%), 1, 2, 6, 7 except for the report by Daviglus et al, 5 which studied younger women. Since the prevalence of a low-risk profile was similar to that of other studies and the relative risk of a low-risk profile for all-cause and CVD mortality is rather modest in Japan, Japanese longevity might not be fully explained by a low-risk profile; that is, additional factors might affect the lower CVD risk in Japan. A recent study by Sekikawa et al has found that middle-aged Japanese men have a lower prevalence of coronary artery calcification than middle-aged men in the USA despite having similar levels of BP and low-density lipoprotein-cholesterol, and a higher incidence of diabetes and smoking. 23 They also suggested that factors other than the classical major factors are involved in risk for CVD. Thus, an investigation of factors that affect a lower CVD risk in Japan, such as green tea consumption, fish consumption or others, should be encouraged. 14, 24, 25 We assessed the magnitude of the CVD risk factors for all-cause mortality. The criteria for each risk factor were the same as those used to define low-risk status. Among those participants with a low-risk profile in the present study, a few with diabetes had the highest HRs for all-cause death, whereas many with high BP, as defined by JNC 7, had a modest HR for all-cause death. As a result, high BP had the highest population-attributable risk fraction for all-cause death, followed by smoking, serum cholesterol, and diabetes for both men and women. Although the populationattributable fraction was not very high, the prevalence of diabetes is increasing steadily, where the prevalence in 2003 (6.9%) was almost double that in 1980 (3.8%). Taking this into consideration, diabetes should have more impact in the future. A distinct difference between men and women was observed regarding the impact of smoking on all-cause mortality. In men, smoking caused a high population risk, being at the same level as high BP, whereas in women smoking contributed much less to population risk compared with high BP. Apparently, this is because the prevalence of smoking is quite different between men and women (men, 64.8%; women, 8.8%) at the baseline survey.
The present study has some methodological limitations. First, we measured risk factors only once at baseline, so we did not have any information about the status of the participants or changes in lifestyle. Second, we used the original definition of a low-risk profile for serum cholesterol. Thus, direct comparisons between the present study and other Western studies are quite difficult. However, as shown in our previous studies, participants whose serum cholesterol level was between 160 and 240 mg/dl (4.14-6.22 mmol/L) had the lowest CVD mortality risk, which might be because Japanese have not been exposed to a high lipid diet for as long as populations in Western countries, especially at the baseline examination of the study. Hence, our approach should be appropriate for the Japanese population.
In conclusion, the benefit of having a low-risk status is apparent in Japan. Individuals with low CVD risk have lower mortality rates due to all-causes and CVD. The most attributable risk factor for all-cause mortality was high BP. Thus, we reconfirmed the importance of maintaining lower BP as a public health strategy, as well as to stop or never start smoking, and maintain modest levels of TC, as well as lower serum glucose levels.
